Literature DB >> 11693343

A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation.

J Raedle1, W Friedl, H Engels, R Koenig, J Trojan, S Zeuzem.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant disorder that typically presents with colorectal cancer secondary to extensive adenomatous polyps of the colon. The molecular basis and clinical phenotype of FAP are well known. Recurrent episodes of severe abdominal pain and a positive fecal occult blood test in an 18-yr-old boy with mild mental retardation and slight dysmorphic features of the face, head, and skeletal system led to the diagnosis of FAP. The clinical workup revealed the presence of over 100 sessile colonic polyps but no polyp formation in the upper GI tract, no cancer development, nor other FAP-associated lesions. To find out whether there is an association between mental retardation and FAP we performed a chromosome analysis including comparative genomic hybridization and an indirect genotype analysis with polymorphic markers from the APC gene region. Cytogenetic analysis showed an interstitial deletion of chromosomal region 5q that was confined to the region 5q21-q22 by comparative genomic hybridization. The deletion, spanning about 10 centimorgans, encompassed the complete APC gene and can be considered as causative for FAP. Moreover, molecular genetic analysis with polymorphic markers flanking the APC gene demonstrated a de novo deletion on the paternal chromosome. Cytogenetically detectable deletions on chromosome 5 including the APC gene generally lead to an associated gene deletion syndrome. Individuals who present with mild mental retardation and dysmorphic features should therefore be investigated for chromosomal deletions. If the deletion encompasses the APC gene, these patients are at high risk of developing FAP and associated complications.

Entities:  

Mesh:

Year:  2001        PMID: 11693343     DOI: 10.1111/j.1572-0241.2001.04674.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  The postsynaptic adenomatous polyposis coli (APC) multiprotein complex is required for localizing neuroligin and neurexin to neuronal nicotinic synapses in vivo.

Authors:  Madelaine M Rosenberg; Fang Yang; Jesse L Mohn; Elizabeth K Storer; Michele H Jacob
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  Phenotypic and molecular characterisation of a de novo 5q deletion that includes the APC gene.

Authors:  Lisa Ofner; Jochen Raedle; Christian Windpassinger; Thomas Schwarzbraun; Peter M Kroisel; Klaus Wagner; Erwin Petek
Journal:  J Hum Genet       Date:  2005-12-20       Impact factor: 3.172

3.  Interstitial Deletion of 5q22.2q23.1 Including APC and TSSK1B in a Patient with Adenomatous Polyposis and Asthenoteratozoospermia.

Authors:  Tanya Kadiyska; Ivan Tourtourikov; Asen Petrov; Ani Chavoushian; Miglena Antalavicheva; Eva-Maria König; Eva Klopocki; Nikolova Vessela; Romil Stanislavov
Journal:  Mol Syndromol       Date:  2018-08-22

Review 4.  Contiguous gene deletion of chromosome 2p16.3-p21 as a cause of Lynch syndrome.

Authors:  Erin E Salo-Mullen; Patricio B Lynn; Lu Wang; Michael Walsh; Anuradha Gopalan; Jinru Shia; Christina Tran; Fung Ying Man; Sean McBride; Mark Schattner; Liying Zhang; Martin R Weiser; Zsofia K Stadler
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

5.  Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities.

Authors:  J L Mohn; J Alexander; A Pirone; C D Palka; S-Y Lee; L Mebane; P G Haydon; M H Jacob
Journal:  Mol Psychiatry       Date:  2014-06-17       Impact factor: 15.992

6.  Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Authors:  Waltraut Friedl; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

7.  Neuronal nicotinic synapse assembly requires the adenomatous polyposis coli tumor suppressor protein.

Authors:  Murali Krishna Temburni; Madelaine M Rosenberg; Narendra Pathak; Russell McConnell; Michele H Jacob
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

8.  Adenomatous Polyposis Coli Protein Deletion in Efferent Olivocochlear Neurons Perturbs Afferent Synaptic Maturation and Reduces the Dynamic Range of Hearing.

Authors:  Tyler T Hickman; M Charles Liberman; Michele H Jacob
Journal:  J Neurosci       Date:  2015-06-17       Impact factor: 6.167

9.  A novel SYBR-based duplex qPCR for the detection of gene dosage: detection of an APC large deletion in a familial adenomatous polyposis patient with an unusual phenotype.

Authors:  Giovana Tardin Torrezan; Felipe Cavalcanti Carneiro da Silva; Ana Cristina Victorino Krepischi; Erika Maria Monteiro dos Santos; Benedito Mauro Rossi; Dirce Maria Carraro
Journal:  BMC Med Genet       Date:  2012-07-16       Impact factor: 2.103

10.  Reduced expression of APC-1B but not APC-1A by the deletion of promoter 1B is responsible for familial adenomatous polyposis.

Authors:  Kiyoshi Yamaguchi; Satoshi Nagayama; Eigo Shimizu; Mitsuhiro Komura; Rui Yamaguchi; Tetsuo Shibuya; Masami Arai; Seira Hatakeyama; Tsuneo Ikenoue; Masashi Ueno; Satoru Miyano; Seiya Imoto; Yoichi Furukawa
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.